NCT05306119 is a NA clinical trial of Rehabilitation method in Rehabilitation, sponsored by Gomel State Medical University.

Who is sponsoring NCT05306119?

NCT05306119 is sponsored by Gomel State Medical University.

What drugs are being tested in NCT05306119?

Interventions in NCT05306119: Rehabilitation method.

What condition does NCT05306119 study?

NCT05306119 studies Rehabilitation, Low Back Pain, Revascularization.

Is NCT05306119 still recruiting?

NCT05306119 is currently active, enrolled. Last updated 31 March 2022.

Last reviewed 2022-03-31 · How we verify

NCT05306119

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Developing a Method of Rehabilitation for Patients After Myocardial Revascularization

Active, enrolled NA Last updated 31 March 2022

What this trial tests

NA trial testing Rehabilitation method in Rehabilitation in 120 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 July 2021

Primary endpoint
30 June 2024

30 June 2026

Quick facts

Lead sponsor	Gomel State Medical University
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	120
Start date	1 July 2021
Primary completion	30 June 2024
Estimated completion	30 June 2026
Sites	1 location across Belarus

Drugs / interventions tested

Rehabilitation method

Conditions studied

Rehabilitation — all drugs for Rehabilitation →
Low Back Pain — all drugs for Low Back Pain →
Revascularization — all drugs for Revascularization →

Sponsor

Gomel State Medical University

Who can join

Adults 40 to 60, any sex, with Rehabilitation or Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

As a result, will be developed: a list of criteria for functional impairment in patients after myocardial revascularization combined with low back pain; a list of criteria for disabilities in patients after myocardial revascularization combined with low back pain; method of medical rehabilitation of patients after myocardial revascularization combined with low back pain; and criteria for evaluating its effectiveness.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Rehabilitation

Currently open trials in the same condition.

NCT07450274 — Rehabilitation of Upper Limbs After Stroke · NA · recruiting
NCT07419217 — Professional Impact of Osteoarticular Trauma · recruiting
NCT07399262 — Music-Augmented Rhythmic Gait Training in Multiple Sclerosis · NA · recruiting
NCT07333079 — Rehabilitation With Biofeedback for People After Stroke · NA · recruiting
NCT07304180 — Exergame vs Balance Training in Hemiplegia · NA · active not recruiting

Other Gomel State Medical University trials

Trials by the same sponsor.

NCT05689177 — Humoral Immunity Study After a Booster Dose of Soberana Plus (FINLAY-FR-1A) Vaccine Against COVID-19 · NA · unknown
NCT05335213 — Urinary Tract Infections in Cirrhosis · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05306119 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gomel State Medical University
Last refreshed: 31 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05306119.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing